---
title: Brigatinib in <em>NF2</em>-Related Schwannomatosis with Progressive Tumors
date: '2024-06-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38904277/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240622182857&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: Brigatinib treatment resulted in radiographic responses
  in multiple tumor types and clinical benefit in a heavily pretreated cohort of patients
  with NF2-SWN. (Funded by the Children''s Tumor Foundation and others; INTUITT-NF2
  ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: Brigatinib treatment resulted in radiographic responses in multiple tumor types and clinical benefit in a heavily pretreated cohort of patients with NF2-SWN. (Funded by the Children's Tumor Foundation and others; INTUITT-NF2 ClinicalTrials.gov number, ...